Welcome to our dedicated page for Cordovacann SEC filings (Ticker: LVRLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cordovacann's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cordovacann's regulatory disclosures and financial reporting.
CordovaCann Corp. reports fiscal year 2025 results as a Canadian cannabis operator with U.S. exposure. Revenue was $14,249,111, slightly above prior years, but the company recorded a net loss of $2,454,615 and negative basic and diluted EPS of $(0.02) per share.
Working capital showed a deficit of $7,413,677 and shareholders’ equity was a deficiency of $(5,205,000) as of June 30, 2025, reflecting heavy liabilities versus assets. CordovaCann operates retail stores in Ontario and Manitoba and holds ancillary cannabis operations in Oregon and Washington, all within a highly regulated and legally complex cross‑border cannabis environment.